DE3661732D1 - Process for producing 4-biphenylylacetic acid - Google Patents
Process for producing 4-biphenylylacetic acidInfo
- Publication number
- DE3661732D1 DE3661732D1 DE8686111429T DE3661732T DE3661732D1 DE 3661732 D1 DE3661732 D1 DE 3661732D1 DE 8686111429 T DE8686111429 T DE 8686111429T DE 3661732 T DE3661732 T DE 3661732T DE 3661732 D1 DE3661732 D1 DE 3661732D1
- Authority
- DE
- Germany
- Prior art keywords
- producing
- biphenylylacetic acid
- biphenylylacetic
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/12—Saturated polycyclic compounds
- C07C61/125—Saturated polycyclic compounds having a carboxyl group bound to a condensed ring system
- C07C61/13—Saturated polycyclic compounds having a carboxyl group bound to a condensed ring system having two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
- C07C51/38—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/42—One oxygen atom attached in position 5
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60184085A JPS6245553A (ja) | 1985-08-23 | 1985-08-23 | フエニル酢酸誘導体の製造法 |
JP60184084A JPS6245554A (ja) | 1985-08-23 | 1985-08-23 | 4−ビフエニリル酢酸の簡易製造法 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3661732D1 true DE3661732D1 (en) | 1989-02-16 |
Family
ID=26502273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8686111429T Expired DE3661732D1 (en) | 1985-08-23 | 1986-08-19 | Process for producing 4-biphenylylacetic acid |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0212617B1 (de) |
KR (1) | KR910006325B1 (de) |
CA (1) | CA1325222C (de) |
DE (1) | DE3661732D1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5705585A (en) | 1993-06-30 | 1998-01-06 | Arqule, Inc. | Aminimide-containing molecules and materials as molecular recognition agents |
CZ181493A3 (en) * | 1992-09-10 | 1994-03-16 | Lilly Co Eli | The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease |
AU704878B2 (en) | 1994-01-05 | 1999-05-06 | Arqule, Inc. | Method of making polymers having specific properties |
US6251928B1 (en) * | 1994-03-16 | 2001-06-26 | Eli Lilly And Company | Treatment of alzheimer's disease employing inhibitors of cathepsin D |
US5734082A (en) | 1994-10-20 | 1998-03-31 | Arqule Inc. | Hydroxyethyl aminimides |
US5712171A (en) | 1995-01-20 | 1998-01-27 | Arqule, Inc. | Method of generating a plurality of chemical compounds in a spatially arranged array |
WO1996031263A1 (en) | 1995-04-06 | 1996-10-10 | Arqule, Inc. | Method for rapid purification, analysis and characterization of collections of chemical compounds |
US5962412A (en) | 1996-06-10 | 1999-10-05 | Arqule, Inc. | Method of making polymers having specific properties |
ES2248107T3 (es) | 1999-08-31 | 2006-03-16 | Incyte San Diego Incorporated | Benciliden-tiazolidindionas y analogos y su utilizacion en el tratamiento de la diabetes. |
AU2002252227A1 (en) | 2001-03-07 | 2002-09-24 | Maxia Pharmaceuticals, Inc. | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
WO2002072543A2 (en) | 2001-03-08 | 2002-09-19 | Maxia Pharmaceuticals, Inc. | Rxr activating molecules |
SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0103710D0 (sv) | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
AU2002352706A1 (en) | 2001-11-15 | 2003-06-10 | Maxia Pharmaceuticals, Inc. | N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases |
US7102000B2 (en) | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
US7196108B2 (en) | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
SE0401762D0 (sv) | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0403086D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
SE0403085D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
TW200831488A (en) | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
CN101684077B (zh) | 2008-09-24 | 2013-01-02 | 浙江九洲药业股份有限公司 | N-酰基联苯丙氨酸的制备方法 |
IN2012DN01968A (de) * | 2009-09-23 | 2015-08-21 | Zhejiang Jiuzhou Pharm Co Ltd |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1167192A (en) * | 1967-12-19 | 1969-10-15 | Boots Pure Drug Co Ltd | Improvements in the Preparation of Propionic Acids |
JPS582934B2 (ja) * | 1974-07-29 | 1983-01-19 | ニツシンセイフン カブシキガイシヤ | 2−(置換アリ−ル)−プロピオン酸の製法 |
DE3013647C2 (de) * | 1980-04-09 | 1985-07-11 | Degussa Ag, 6000 Frankfurt | Verfahren zur Herstellung von 5-Arylidenhydantoinen (B) |
-
1986
- 1986-08-18 CA CA000516132A patent/CA1325222C/en not_active Expired - Fee Related
- 1986-08-19 DE DE8686111429T patent/DE3661732D1/de not_active Expired
- 1986-08-19 EP EP86111429A patent/EP0212617B1/de not_active Expired
- 1986-08-23 KR KR1019860006978A patent/KR910006325B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR870002043A (ko) | 1987-03-28 |
CA1325222C (en) | 1993-12-14 |
EP0212617B1 (de) | 1989-01-11 |
KR910006325B1 (ko) | 1991-08-20 |
EP0212617A1 (de) | 1987-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT41786A (en) | Process for producing 1-carba-/1-dethia/-3-cepheme-4-carboxylic acid derivatives | |
HUT37149A (en) | Process for producing quinoline- and naphtiridine-carboxylic acid derivatives | |
DE3661732D1 (en) | Process for producing 4-biphenylylacetic acid | |
HUT44757A (en) | Process for producing phenoxyacetic acid derivatives | |
HUT41774A (en) | Process for producing thiazolidine-carboxylic acid | |
HUT42051A (en) | Process for producing certain enanthiomere pairs of alpha-cyano-3-phenoxy-4-fluoro-benzyl-ester of permetrinic acid | |
HUT43079A (en) | Process for producing new cepheme-derivatives | |
GR862276B (en) | Improved process for tetrafluorobenzoic acid | |
EP0199943A3 (en) | Process for producing d-alpha-amino acids | |
YU141886A (en) | Process for producing l-ascorbinic acid | |
HUT38337A (en) | Process for producing new quinoline-carboxylic acid derivatives | |
HUT41799A (en) | Process for producing 3-propenyl-cephalosporin-solvates | |
GB2177997B (en) | Process for producing microcapsules | |
HUT40789A (en) | Process for producing 2,3,4,9-tetrahydro-1h-carbazol-1-acetic acid | |
HUT46021A (en) | Process for producing ceph-3-eme-4-carboxylic acid derivatives | |
DE3662884D1 (en) | Process for producing 2-hydroxy-4-methyltetrahydropyran | |
HUT43830A (en) | Process for producing new dopamine-beta-hydrolaseinhibitores | |
DE3665451D1 (en) | Process for preparing polycarboxylic acid | |
ZA866061B (en) | Process for tetrafluorobenzoic acid | |
HUT46023A (en) | Process for producing purin-9-yl-alkoxy-methyl-phosphonic acid derivatives | |
HUT43613A (en) | Process for producing netilmycine | |
YU142186A (en) | Process for producing aluminiumtrioxide | |
HUT38912A (en) | Process for producing quinolon- and naphtiridon-carboxylic acid derivatives | |
PH23427A (en) | Process for producing acid type aminocarboxylic acid | |
HUT41767A (en) | Process for producing quinolon-carboxylic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |